“Efficacy and Safety of Bevacizumab in Neoadjuvant and Concurrent Chemoradiotherapy for Refractory Cervical Cancer Patients”. 2024. Biomolecules and Biomedicine 24 (6): 1586–1594. https://doi.org/10.17305/bb.2024.10528.